Direct Oral Anticoagulants (DOACs)

www.northernlincolnshireapc.nhs.uk

available oral anticoagulants. In recent years, direct oral anticoagulants (DOACs) have gained approval for the treatment and prevention of venous thromboembolism (VTE) and for stroke prevention in patients with non-valvular atrial fibrillation (NVAF). They have similar or better efficacy and safety compared with warfarin and are

Direct, Oral, Anticoagulant, Venous, Coda, Oral anticoagulant, Direct oral anticoagulants

Guidance on converting between anticoagulants

www.gloshospitals.nhs.uk

4. National Institute for Health and Care Excellence (NICE). CG 144. Venous thromboembolic diseases: the management of venous thromboembolic diseases and the role of thrombophilia testing. ... Alings M et al. European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation ...

Oral, Anticoagulant, Venous, Oral anticoagulant

Transition of Anticoagulants 2019 - Thomas Land Publishers ...

store.thomasland.com

7. Buller HR, Prins MH, Lensing AW, et al. Oral rivaroxaban for the treatment of symptomatic pulmonary embolism (EINSTEIN PE). N Engl J Med. 2012;366:1287-1297. 8. Bauersachs R, Berkowitz SD, Brenner B, et al. Oral rivaroxaban for the treatment of symptomatic venous thromboembolism (EINSTEIN). N Engl J Med. 2010;363:2499-2510. 9.

Oral, Anticoagulant, Venous

Transition of Anticoagulants 2016 - Thomas Land

www.thomasland.com

7. Buller HR, Prins MH, Lensing AW, et al. Oral rivaroxaban for the treatment of symptomatic pulmonary embolism (EINSTEIN PE). N Engl J Med. 2012;366:1287-1297. 8. Bauersachs R, Berkowitz SD, Brenner B, et al. Oral rivaroxaban for the treatment of symptomatic venous thromboembolism (EINSTEIN). N Engl J Med. 2010;363:2499-2510. 9.

Oral, Anticoagulant, Venous

Oral Anticoagulant Comparison Chart - Remedi SeniorCare

www.remedirx.com

Oral Anticoagulant Comparison Chart . Venous Thromboembolism (VTE) is manifested as Deep Venous Thrombosis (DVT) and Pulmonary Embolism (PE). VTE prophylaxis and treatment is critical to survival and the incidence of VTE practically doubles for every decade over age 50 with a slightly higher incidence in males (1). Anticoagulant

Oral, Venous

HIGHLIGHTS OF PRESCRIBING INFORMATION o For patients …

docs.boehringer-ingelheim.com

1.2 Treatment of Deep Venous Thrombosis and Pulmonary Embolism PRADAXA is indicated for the treatment of deep venous thrombosis and pulmonary embolism in patients who have been treated with a parenteral anticoagulant for 5-10 days. 1.3 Reduction in the Risk of Recurrence of Deep Venous Thrombosis and Pulmonary Embolism

Venous

Oral Anticoagulants For Venous